4.05
price up icon3.05%   +0.12
after-market  After Hours:  4.05 
loading

Aldeyra Therapeutics Inc Stock (ALDX) Forecast

The Aldeyra Therapeutics Inc (ALDX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $3.4982, representing a -13.62% decrease from the current price of $4.05. The highest analyst price target is $3.9824, and the lowest is $3.0141.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ALDX Price Target
Average 2.0044 (-50.51% Downside)
loading

Is Aldeyra Therapeutics Inc (ALDX) A Buy Now?

Oscillators
Name Value Action
RSI(14) 56.35 Neutral
STOCH(9,6) 31.01 Neutral
STOCHRSI(14) 35.36 Neutral
MACD(12,26) 0.1038 Sell
ADX(14) 26.40 Buy
William %R -62.32 Neutral
CCI(14) 11.77 Neutral
Buy: 1 Sell: 1 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
3.938
Buy
3.9785
Buy
MA20
4.1173
Sell
3.9216
Buy
MA50
3.6522
Buy
3.7145
Buy
MA100
3.446
Buy
3.7529
Buy
MA200
4.4268
Sell
4.5094
Sell
Buy: 7 Sell: 3 Neutral: 0
Summary: Buy
According to our latest analysis, ALDX could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 4 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on ALDX, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 56.35 indicates that ALDX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 31.01 indicates that ALDX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 35.36 indicates that ALDX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 26.4 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 11.77 indicates that ALDX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term ALDX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Aldeyra Therapeutics Inc financial reports and earnings history, Aldeyra Therapeutics Inc (ALDX) stock could reach $0.6235 by 2030, $2.1216 by 2040 and $11.29 by 2050. See the projected annual prices until 2050 of the Aldeyra Therapeutics Inc stock below:

  • Aldeyra Therapeutics Inc (ALDX) is expected to reach an average price of $2.6259 in 2035, with a high prediction of $2.5891 and a low estimate of $1.0874. This indicates an $-35.16% rise from the last recorded price of $4.05.
  • Aldeyra Therapeutics Inc (ALDX) stock is projected to chart a bullish course in 2040, with an average price target of $1.9516, representing an $-51.81% surge from its current level. The forecast ranges from a conservative $0.1234 to a sky-high $2.1216.
  • Our analysts predict Aldeyra Therapeutics Inc (ALDX) to jump -10.03% by 2045, soaring from $3.739 to an average price of $3.644, potentially reaching $3.4506. While $3.739 is the low estimate, the potential upside is significant.
  • Aldeyra Therapeutics Inc (ALDX) stock is expected to climb by 2050, reaching an average of $11.37, a $180.80% jump from its current level. However, a wide range of estimates exists, with high and low targets of $11.29 and $11.53, respectively, highlighting the market's uncertainty.

Aldeyra Therapeutics Inc Stock (ALDX) Year by Year Forecast

Aldeyra Therapeutics Inc Stock (ALDX) Price Forecast for 2024

Our forecast for ALDX stock price in 2024 now indicates an average price target of $3.8765 with a high forecast of $7.7266 and a low forecast of $0.0265. The average prediction reflects an decrease of -4.28% from the last recorded price of $4.05.
Month Average Low High Change from today's price
May, 2024 $3.5516 $3.0141 $3.9824 -12.31%
June, 2024 $2.5382 $2.3482 $3.9007 -37.33%
July, 2024 $1.604 $0.6349 $3.1399 -60.39%
August, 2024 $1.1557 $0.7415 $1.7232 -71.46%
September, 2024 $0.0815 $0.0265 $1.689 -97.99%
October, 2024 $1.4831 $0.0856 $2.0031 -63.38%
November, 2024 $1.4098 $0.6631 $1.8298 -65.19%
December, 2024 $1.8656 $1.2764 $2.1264 -53.94%

Aldeyra Therapeutics Inc Stock (ALDX) Price Forecast for 2025

Aldeyra Therapeutics Inc Stock (ALDX) is expected to reach an average price of $2.0912 in 2025, with a high prediction of $4.0929 and a low estimate of $0.0895. This indicates an -48.37% fall from the last recorded price of $4.05.
Month Average Low High Change from today's price
January, 2025 $1.0222 $0.3431 $3.8439 -74.76%
February, 2025 $1.8289 $0.9214 $2.7505 -54.84%
March, 2025 $1.5037 $1.1755 $2.4972 -62.87%
April, 2025 $0.5737 $0.3678 $1.4089 -85.84%
May, 2025 $1.642 $1.6195 $1.417 -59.46%
June, 2025 $0.7762 $1.1754 $1.6028 -80.83%
July, 2025 $0.3805 $0.0895 $1.1205 -90.61%
August, 2025 $0.6671 $0.1004 $1.3888 -83.53%
September, 2025 $2.8729 $0.1063 $3.1929 -29.06%
October, 2025 $2.8496 $2.2121 $3.9604 -29.64%
November, 2025 $2.1162 $1.8062 $3.7887 -47.75%
December, 2025 $3.282 $1.8054 $4.0929 -18.96%

Aldeyra Therapeutics Inc Stock (ALDX) Price Forecast for 2026

The predicted value for Aldeyra Therapeutics Inc (ALDX) in 2026 is set at an average of $7.5569. Estimates vary from a peak of $12.56 to a trough of $2.5587, indicating an +86.59% surge from the present price of $4.05.
Month Average Low High Change from today's price
January, 2026 $3.0287 $2.5587 $5.0395 -25.22%
February, 2026 $3.3253 $2.6378 $3.4778 -17.89%
March, 2026 $3.7011 $3.0036 $4.6811 -8.61%
April, 2026 $8.7578 $2.9194 $11.09 +116.24%
May, 2026 $9.2544 $6.8161 $11.02 +128.50%
June, 2026 $7.7102 $6.4227 $9.6311 +90.38%
July, 2026 $7.8669 $6.8394 $9.4277 +94.24%
August, 2026 $8.3627 $6.716 $12.56 +106.49%
September, 2026 $8.5893 $7.7319 $9.8402 +112.08%
October, 2026 $7.486 $6.546 $8.7985 +84.84%
November, 2026 $6.0418 $5.2135 $7.6165 +49.18%
December, 2026 $6.0084 $4.781 $6.5984 +48.36%

Aldeyra Therapeutics Inc Stock (ALDX) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Aldeyra Therapeutics Inc (ALDX) is $3.3104, with a high forecast of $6.6201 and a low forecast of $0.000826. This indicates an -18.26% decrease from the last price of $4.05.
Month Average Low High Change from today's price
January, 2027 $5.6151 $4.7159 $6.2276 +38.64%
February, 2027 $4.9017 $4.7017 $6.2434 +21.03%
March, 2027 $4.5876 $4.2276 $6.6201 +13.27%
April, 2027 $3.9842 $3.4542 $4.9159 -1.62%
May, 2027 $0.24 $0.23 $4.2134 -94.07%
June, 2027 $0.8767 $0.000826 $1.3117 -78.35%
July, 2027 $0.5633 $0.5433 $1.2958 -86.09%
August, 2027 $1.8191 $0.5125 $2.41 -55.08%
September, 2027 $0.2158 $0.1058 $2.1583 -94.67%
October, 2027 $0.2824 $0.1726 $0.2924 -93.03%
November, 2027 $0.9082 $0.0607 $1.2399 -77.57%
December, 2027 $1.9849 $0.8174 $2.8279 -50.99%

Aldeyra Therapeutics Inc Stock (ALDX) Price Forecast for 2028

In 2028, Aldeyra Therapeutics Inc (ALDX) is projected to reach an average price of $5.2685, with a high projection of $8.553 and a low estimate of $1.984. This indicates an +30.09% rise from the last price of $4.05.
Month Average Low High Change from today's price
January, 2028 $4.2507 $1.984 $5.2915 +4.96%
February, 2028 $3.9173 $3.5573 $4.919 -3.28%
March, 2028 $2.724 $2.474 $4.0164 -32.74%
April, 2028 $2.8806 $2.3564 $3.1111 -28.87%
May, 2028 $3.0664 $2.399 $3.3481 -24.29%
June, 2028 $4.1031 $3.1056 $4.1231 +1.31%
July, 2028 $3.6389 $3.4489 $4.7114 -10.15%
August, 2028 $4.6955 $3.3081 $4.7055 +15.94%
September, 2028 $4.8022 $4.3139 $5.6222 +18.57%
October, 2028 $8.108 $4.5254 $8.553 +100.20%
November, 2028 $7.8647 $6.6463 $8.5055 +94.19%
December, 2028 $8.3913 $6.853 $8.4363 +107.19%

Aldeyra Therapeutics Inc Stock (ALDX) Price Forecast for 2029

The 2029 price forecast for Aldeyra Therapeutics Inc Stock (ALDX) is $4.8946 on average, with a high prediction of $9.7296 and a low estimate of $0.0596. This represents an +20.86% increase from the previous price of $4.05.
Month Average Low High Change from today's price
January, 2029 $5.4971 $3.2388 $9.7296 +35.73%
February, 2029 $5.9388 $5.3696 $6.1154 +46.64%
March, 2029 $5.4504 $4.9362 $6.2129 +34.58%
April, 2029 $4.0462 $4.0262 $5.6796 -0.09%
May, 2029 $0.4071 $0.6371 $4.6645 -89.95%
June, 2029 $0.2645 $0.0596 $0.8795 -93.47%
July, 2029 $1.1853 $0.2187 $1.3903 -70.73%
August, 2029 $0.9817 $0.7645 $1.7537 -75.76%
September, 2029 $0.5484 $0.265 $0.805 -86.46%
October, 2029 $1.3068 $0.6517 $0.6168 -67.73%
November, 2029 $0.6235 $1.2601 $0.7784 -84.61%
December, 2029 $1.1918 $0.3568 $3.2232 -70.57%

Aldeyra Therapeutics Inc Stock (ALDX) Price Forecast for 2030

Aldeyra Therapeutics Inc Stock (ALDX) is expected to reach an average price of $2.6371 in 2030, with a high forecast of $4.519 and a low forecast of $0.7552. This signifies an -34.89% decrease from the last price of $4.05.
Month Average Low High Change from today's price
January, 2030 $1.0985 $0.7552 $0.6235 -72.88%
February, 2030 $1.9752 $1.6802 $1.6852 -51.23%
March, 2030 $2.762 $2.4169 $2.542 -31.80%
April, 2030 $3.1903 $3.1636 $3.127 -21.23%
May, 2030 $4.202 $3.612 $3.777 +3.75%
June, 2030 $2.7637 $2.8821 $3.4186 -31.76%
July, 2030 $2.6021 $2.8921 $2.8088 -35.75%
August, 2030 $2.2988 $2.5988 $2.3157 -43.24%
September, 2030 $2.5872 $2.0922 $2.8055 -36.12%
October, 2030 $1.9239 $2.4106 $2.0422 -52.50%
November, 2030 $2.5416 $2.1356 $2.3888 -37.24%
December, 2030 $5.529 $3.033 $4.519 +36.52%
$82.13
price up icon 1.51%
$156.53
price up icon 1.92%
$28.57
price up icon 1.49%
$147.36
price up icon 2.83%
$87.95
price up icon 0.85%
$375.29
price up icon 0.67%
Cap:     |  Volume (24h):